Renal function in advanced heart failure (Q37905951)

25 August 2017

1 reference

title

Renal function in advanced heart failure (English)

1 reference

25 August 2017

0 references

2

Javed Butler

1 reference

25 August 2017

Gregory Giamouzis

1

1 reference

PubMed ID

21790968

25 August 2017

Filippos Triposkiadis

series ordinal

3

1 reference

25 August 2017

21 July 2011

1 reference

25 August 2017

Congestive Heart Failure

1 reference

25 August 2017

17

1 reference

25 August 2017

4

1 reference

25 August 2017

180-188

1 reference

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Non-cardiac comorbidities in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Peri-operative renal function and outcome after orthotopic heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Incremental value of renal function in risk prediction with the Seattle Heart Failure Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Utility of the Seattle Heart Failure Model in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Innate inflammation in myocardial perfusion and its implication for heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The immune system and chronic heart failure: is the heart in control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Diuretic therapy and resistance in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Blood urea nitrogen and serum creatinine: not married in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Cardio-Kidney-Damage: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Cardiorenal syndrome in acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal biomarkers of kidney injury in cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

21 January 2018

Cardiorenal syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

HFSA 2010 Comprehensive Heart Failure Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Cardiorenal syndrome in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Congestion as a therapeutic target in acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Spironolactone use and renal toxicity: population based longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Inotropes in the management of acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The effects of dobutamine on renal sympathetic activity in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CH

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Myocardial efficiency during levosimendan infusion in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Levosimendan: from basic science to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz e

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

The role of ultrafiltration in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00240.X

10.1111/J.1751-7133.2011.00240.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21790968